Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Tacrograf 0.25 Capsule

Prescription Icon
Prescription Required

Marketer

Eris Lifesciences Ltd

Salt Composition

Tacrolimus (0.25mg)

Overview Tacrograf 0.25 Capsule

Prograf 0.25mg capsules, used post-transplant (e.g., liver, kidney, heart), suppress the immune system to prevent organ rejection. This immunosuppressant's dosage and frequency depend on transplant type, weight, and other medications; always follow your physician's instructions. Administer on an empty stomach (at least one hour before or two hours after meals). Consistent use is crucial; discontinuation risks organ rejection. Prograf 0.25mg capsules can cause or exacerbate diabetes and kidney issues—requiring immediate medical attention—and other side effects like tremors, infections, hypertension, headaches, and sleep disturbances. Report persistent or worsening side effects. Weakened immunity increases infection susceptibility. Inform your doctor of pre-existing conditions (kidney, liver, or heart disease, diabetes, hypertension) and all current medications (especially anti-infectives, analgesics, and arthritis treatments), as interactions are possible. Minimize sun and UV exposure due to increased skin cancer risk. Reliable contraception is essential for both genders. Use during pregnancy or breastfeeding is generally discouraged unless medically necessary. Regular medical checkups, including frequent blood pressure monitoring, are vital throughout treatment.

Uses of Tacrograf 0.25 Capsule

Preventing graft rejection in transplant recipients

Major Benefits of Tacrograf 0.25 Capsule:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Consume Tacrograf 0.25 Capsule on an empty stomach.

Common Side effects of Tacrograf 0.25 Capsule:

  • High blood pressure
  • Increased glucose level in blood
  • Kidney damage
  • Insomnia (difficulty in sleeping)
  • Tremors
  • Headache
  • Abnormal liver function tests
  • Infection

How to use Tacrograf 0.25 Capsule:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Consume Tacrograf 0.25 Capsules on an empty stomach.

How Tacrograf 0.25 Capsule works:

Immunosuppressant Tacrograf 0.25mg capsules reduce the body's immune reaction after organ transplantation (such as kidney, liver, or heart). This action facilitates the body's acceptance of the transplanted organ.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Tacrograf 0.25 Capsules is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Tacrograf 0.25 Capsule during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against the risks before prescribing this medication. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Tacrograf 0.25 Capsule while breastfeeding is likely unsafe. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

Taking a 0.25mg Tacrograf capsule might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.

KidneyKidneyCAUTION

Patients with kidney impairment should use Tacrograf 0.25 Capsule cautiously, as dose modification may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Individuals with hepatic impairment should exercise caution when using Tacrograf 0.25 Capsule. Dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Tacrograf 0.25 Capsule :

Should you forget a Tacrograf 0.25 Capsule dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Tacrograf 0.25 Capsule

LabelValue
Chemical Category Macrolide Antibiotics
Developing Habits No.
Treatment Category Cancer Medications

FAQs on Tacrograf 0.25 Capsule

Tacrograf 0.25 Capsule is a macrolide antibiotic primarily used post-organ transplant. Its immunosuppressive action helps prevent rejection following kidney, heart, or liver transplantation.
While using Tacrograf 0.25 Capsule, avoid live vaccines—those containing weakened, but still live, pathogens. This includes measles, mumps, rubella, BCG (TB), yellow fever, chicken pox, and typhoid vaccines, as well as oral polio and nasal flu vaccines.
Tacrograf 0.25 Capsules should be avoided by individuals with allergies to its components, weakened immune systems, high blood pressure, or kidney failure. Pregnant or breastfeeding women, and those planning to receive live vaccines (such as MMR), should also avoid this medication.
Before starting treatment, tell your doctor if you're pregnant, have allergies, a chronic infection, high blood sugar, high blood pressure, high potassium levels, or a weakened immune system. Also disclose any current medications, recent vaccines, or upcoming live vaccinations.
Tacrolimus (Tacrograf 0.25 Capsule) weakens the immune system, raising your risk of infection and potentially certain cancers, such as skin and lymphoma. This medication's immunosuppressive effect reduces your body's ability to fight infections. Consult your doctor before starting this medication and immediately if you experience any infection symptoms, including fever, sweats, chills, cough, flu-like symptoms, muscle aches, or skin redness, warmth, or pain.
Tacrograf 0.25 Capsules are not a controlled substance and do not have abuse potential. Controlled substances require authorization from medical professionals and regulatory bodies due to their potential for misuse.
Tacrograf 0.25 Capsule
159
MRP 184
13% off